{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:40:27Z","timestamp":1773218427203,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.diabres.2019.107870","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:15:07Z","timestamp":1569323707000},"page":"107870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk of macrovascular complications in statin-treated patients developing diabetes"],"prefix":"10.1016","volume":"157","author":[{"given":"Yin-Huei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cih","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Nien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chih","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.107870_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2019.107870_b0010","article-title":"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases","volume":"348","author":"Dormuth","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2019.107870_b0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40256-013-0053-0","article-title":"Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?","volume":"14","author":"Navarese","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.diabres.2019.107870_b0020","doi-asserted-by":"crossref","DOI":"10.1177\/2050312115605518","article-title":"Risk of new-onset diabetes associated with statin use","author":"Beckett","year":"2015","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.diabres.2019.107870_b0025","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/CIRCULATIONAHA.112.122135","article-title":"Statins and risk of new-onset diabetes mellitus","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2019.107870_b0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11886-013-0461-4","article-title":"Statin treatment, new-onset diabetes, and other adverse effects :a systematic review","volume":"16","author":"Bang","year":"2014","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.diabres.2019.107870_b0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/00325481.2017.1292107","article-title":"New onset diabetes mellitus induced by statins: current evidence","volume":"129","author":"Chrysant","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.diabres.2019.107870_b0040","doi-asserted-by":"crossref","unstructured":"Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215\u20132222. https:\/\/doi:10.1016\/S0140-6736(10)60484-9.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"10.1016\/j.diabres.2019.107870_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2019.107870_b0050","doi-asserted-by":"crossref","first-page":"e1000278","DOI":"10.1371\/journal.pmed.1000278","article-title":"Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review","volume":"7","author":"Sarwar","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2019.107870_b0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11883-014-0458-5","article-title":"Statins, glycemia, anddiabetes mellitus: another point of view","volume":"16","author":"Stulc","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.diabres.2019.107870_b0060","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.amjcard.2017.06.054","article-title":"balancing primary prevention and statin-induced diabetes mellitus prevention","volume":"120","author":"Rochlani","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2019.107870_b0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.diabres.2017.08.008","article-title":"Clinical significance of diabetes likely induced by statins: evidence from a large population-based cohort","volume":"133","author":"Corrao","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2019.107870_b0070","unstructured":"Bureau of National Health Insurance. National Health Insurance Research Database. Taiwan. Zhunan, Taiwan. Bureau of National Health Insurance, Department of Health. Available from http:\/\/nhird.nhri.org.tw\/en\/index.html. Accessed 2015."},{"key":"10.1016\/j.diabres.2019.107870_b0075","unstructured":"Parsons LS. Performing a 1:N Case-Control Match on Propensity Score. Proceedings of the 29th Annual SAS Users Group International Conference; May 9-12, 2004. Available from https:\/\/www.lexjansen.com\/cgi-bin\/xsl_transform.php?x=sugi29.Accessed."},{"key":"10.1016\/j.diabres.2019.107870_b0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2019.107870_b0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/dom.12254","article-title":"Is statin-induced diabetes clinically relevant? a comprehensive review of the literature","volume":"16","author":"Bell","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2019.107870_b0090","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2019.107870_b0095","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events-A scientific statement from the american heart association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabres.2019.107870_b0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2019.107870_b0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of acute myocardial infarction cases in the national health insurance research database in Taiwan","volume":"24","author":"Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"10.1016\/j.diabres.2019.107870_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2015.07.075","article-title":"Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan","volume":"201","author":"Cheng","year":"2015","journal-title":"Int J Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719310514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719310514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:08:33Z","timestamp":1759172913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719310514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":22,"alternative-id":["S0168822719310514"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.107870","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of macrovascular complications in statin-treated patients developing diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.107870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107870"}}